Literature DB >> 25711486

Overexpression of Ku80 suggests poor prognosis of locally advanced esophageal squamous cell carcinoma patients.

Shuai Wang1, Zhou Wang, Xiangyan Liu, Yu Liu, Yang Jia.   

Abstract

BACKGROUND: Recent studies have shown that Ku80 expression was implicated in development and progression of malignant tumors. In the present study, we analyzed for the first time the expression of Ku80 in locally advanced esophageal squamous cell carcinoma (ESCC) and its correlation with clinicopathologic features and patient survival.
METHODS: The expression profile of Ku80 was analyzed in 126 cases of locally advanced ESCC and 79 cases of normal subjects as control using immunohistochemistry and Western blot. The associations of Ku80 expression with clinicopathological features were estimated by χ (2) test. We further performed univariate and multivariate analyses to identify prognostic factors for overall survival (OS) of patients.
RESULTS: Immunohistochemistry and Western blot analyses both showed the Ku80 protein expression was significantly higher in ESCC than normal esophageal mucosa and corresponding healthy esophageal mucosa. Statistical analysis suggested a significant correlation of Ku80 overexpression with the tumor size (p = 0.037), differentiation degree (p = 0.018), depth of invasion (p = 0.020), lymph node metastasis (p = 0.045), clinicopathological staging (p = 0.001), and tumor recurrence (p = 0.011) in locally advanced ESCC patients. Moreover, overexpression of Ku80 was associated with reduced OS of patients after surgery (p = 0.001). Multivariate analysis with a Cox proportional hazards model further suggested that Ku80 expression was an independent prognostic indicator for patients' OS (p = 0.029).
CONCLUSIONS: Ku80 was a predictor of tumor's progression and prognosis of locally advanced ESCC patients. All of these results indicate that assessment of Ku80 level could improve stratification of locally advanced ESCC patients.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25711486     DOI: 10.1007/s00268-015-3023-7

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  29 in total

1.  Dimerization and nuclear localization of ku proteins.

Authors:  M Koike; T Shiomi; A Koike
Journal:  J Biol Chem       Date:  2001-01-10       Impact factor: 5.157

Review 2.  Ku autoantigen: a multifunctional DNA-binding protein.

Authors:  R Tuteja; N Tuteja
Journal:  Crit Rev Biochem Mol Biol       Date:  2000       Impact factor: 8.250

3.  Adjuvant radiotherapy after modified Ivor-Lewis esophagectomy: can it prevent lymph node recurrence of the mid-thoracic esophageal carcinoma?

Authors:  Gang Chen; Zhou Wang; Xiang-Yan Liu; Fan-Ying Liu
Journal:  Ann Thorac Surg       Date:  2009-06       Impact factor: 4.330

4.  Clinicopathological significance of KU70/KU80, a key DNA damage repair protein in breast cancer.

Authors:  Alaa T Alshareeda; Ola H Negm; Nada Albarakati; Andrew R Green; Christopher Nolan; Rebeka Sultana; Srinivasan Madhusudan; Ahmed Benhasouna; Paddy Tighe; Ian O Ellis; Emad A Rakha
Journal:  Breast Cancer Res Treat       Date:  2013-04-28       Impact factor: 4.872

5.  The membrane form of the DNA repair protein Ku interacts at the cell surface with metalloproteinase 9.

Authors:  Sylvie Monferran; Jenny Paupert; Stéphanie Dauvillier; Bernard Salles; Catherine Muller
Journal:  EMBO J       Date:  2004-09-23       Impact factor: 11.598

6.  Characterization of estrogen response element binding proteins as biomarkers of breast cancer behavior.

Authors:  Traci L Kruer; Timothy D Cummins; David W Powell; James L Wittliff
Journal:  Clin Biochem       Date:  2013-07-16       Impact factor: 3.281

7.  ShRNA-mediated Ku80 gene silencing inhibits cell proliferation and sensitizes to gamma-radiation and mitomycin C-induced apoptosis in esophageal squamous cell carcinoma lines.

Authors:  Qing-Shan Yang; Jin-Long Gu; Li-Qing Du; Li-Li Jia; Li-Li Qin; Yong Wang; Fei-Yue Fan
Journal:  J Radiat Res       Date:  2008-04-09       Impact factor: 2.724

Review 8.  Environmental causes of esophageal cancer.

Authors:  Farin Kamangar; Wong-Ho Chow; Christian C Abnet; Sanford M Dawsey
Journal:  Gastroenterol Clin North Am       Date:  2009-03       Impact factor: 3.806

9.  The expression pattern of Ku correlates with tumor radiosensitivity and disease free survival in patients with rectal carcinoma.

Authors:  Yasuhiro Komuro; Toshiaki Watanabe; Yoshio Hosoi; Yoshihisa Matsumoto; Keiichi Nakagawa; Nelson Tsuno; Shinsuke Kazama; Joji Kitayama; Norio Suzuki; Hirokazu Nagawa
Journal:  Cancer       Date:  2002-09-15       Impact factor: 6.860

10.  Radiosensitisation of bladder cancer cells by panobinostat is modulated by Ku80 expression.

Authors:  Blaz Groselj; Martin Kerr; Anne E Kiltie
Journal:  Radiother Oncol       Date:  2013-08-06       Impact factor: 6.280

View more
  5 in total

1.  Clinical values of Ku80 upregulation in superficial esophageal squamous cell carcinoma.

Authors:  Shuai Wang; Junjie Xi; Zongwu Lin; Jiatao Hao; Can Yao; Cheng Zhan; Wei Jiang; Yu Shi; Qun Wang
Journal:  Cancer Med       Date:  2018-03-13       Impact factor: 4.452

2.  XRCC5 cooperates with p300 to promote cyclooxygenase-2 expression and tumor growth in colon cancers.

Authors:  Zhifeng Zhang; Fufu Zheng; Zhenlong Yu; Jiajiao Hao; Miao Chen; Wendan Yu; Wei Guo; Yiming Chen; Wenlin Huang; Zhijun Duan; Wuguo Deng
Journal:  PLoS One       Date:  2017-10-19       Impact factor: 3.240

3.  Deficiency of Ku Induces Host Cell Exploitation in Human Cancer Cells.

Authors:  Okay Saydam; Nurten Saydam
Journal:  Front Cell Dev Biol       Date:  2021-03-29

4.  High expression of cyclooxygenase 2 is an indicator of prognosis for patients with esophageal squamous cell carcinoma after Ivor Lewis esophagectomy.

Authors:  Dongxin Hu; Mingyan Zhang; Shuai Wang; Zhou Wang
Journal:  Thorac Cancer       Date:  2016-01-04       Impact factor: 3.500

5.  Identification of key genes and pathways at the downstream of S100PBP in pancreatic cancer cells by integrated bioinformatical analysis.

Authors:  Yu-Jie Lu; Yi Yang; Ting-Hui Hu; Wei-Ming Duan
Journal:  Transl Cancer Res       Date:  2021-02       Impact factor: 1.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.